Nuvation Bio Inc.

Key metrics

Financial performance

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (379 filings)

Recent press releases

• Nuvation Bio to Present at the Jefferies Global Healthcare Conference2026-05-27

  A live webcast of the fireside chat will be available on the Investor Relations section of the Nuvation Bio website. An archived recording will be available for 90 days following the event.

• Nuvation Bio to Present New Quality-of-Life Data for IBTROZI® (Taletrectinib) in Patients with ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2026 Annual Meeting2026-05-27

  _88% of TRUST-II patients reported improved or stable quality of life at first assessment, with the majority sustaining that benefit throughout treatment_

• Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer2026-05-13

  _Thermo Fisher Scientific, the world leader in serving science, will now manufacture drug product for Nuvation Bio in the United States_

• Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer2026-05-06

  _Application includes updated TRUST-I TKI-naïve median duration of response (mDOR) and median progression-free survival (mPFS) of more than 4 years, as well as TRUST-II TKI-pretreated mDOR of nearly 20 months_

• Nuvation Bio to Participate in Upcoming Investor Conferences2026-05-05

  Live webcasts of each fireside chat will be available on the Investor Relations section of the Nuvation Bio website. An archived recording will be available for 90 days following each event.

Similar companies

The largest companies sharing Nuvation Bio Inc.'s SEC industry classification (pharmaceutical preparations).